<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The aim of this study was to demonstrate the efficacy of laparoscopic antireflux surgery in controlling <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> progression, through functional study </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Between January 2008 and December 2009, 21 patients with a preoperative diagnosis of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> underwent Nissen-Rossetti fundoplication </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> patients underwent preoperatively a 24-hour pH-metry (100%) </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty patients (95.2%) had postoperative pH monitoring at six months, 16 patients at 12 months (76.2%), eight at 24 months (57.14%) </plain></SENT>
<SENT sid="4" pm="."><plain>Median De Meester and Johnson score was preoperatively 18.55 (range 8.6-179.7), at six months 7.65 (range 6.4-13), at 12 months 7.5 (range 6.4-14.2), at 24 months 11.95 (range 6.4-20.6) </plain></SENT>
<SENT sid="5" pm="."><plain>CLE was still present in 18 patients (18/21, 85.7%), but no patient developed <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients with gastric- and one patient with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> showed complete regression at 12 and 24 months after fundoplication (3/21, 14.3%) </plain></SENT>
<SENT sid="7" pm="."><plain>Symptom control alone does not manage <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> after surgery, and postoperative 24-hour pH-metry confirms <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> abolition </plain></SENT>
<SENT sid="8" pm="."><plain>A persistent reflux is more likely to develop <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> than in monitored patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Only the presence of intact and effective anti-reflux wrap guarantees protection of the esophagus against CLE progression or its regression </plain></SENT>
<SENT sid="10" pm="."><plain>Functional study after surgery identifies patients with Barrett's progression risk </plain></SENT>
</text></document>